Validation of a formulation from UTCBS to reduce recurrence rates after local treatment of colorectal cancer,

Jun 29, 2023 | Laboratory UTCBS, Research

Start-up Imisca and Erganeo have signed an exclusive license for a new gel-forming solution to reduce recurrence rates after local treatment of colorectal cancer, improve patient survival and optimize treatment. Colorectal cancer is one of the most common cancers,...

UTCBS takes part in the 6th NanoMed Workshop in Patras (Greece)

Jun 26, 2023 | Laboratory UTCBS, Seminar, Symposium

From July 10 to 12, 2023, the 6th EMJMD NanoMed Workshop will be held in Patras (Greece) on the theme of positioning Nanomedicine in the post-vaccine RNA-messenger era. The UTCBS is fully involved in this event, with Karine Andrieux and Kair Alhareth, participating to...

The French Society of Nanomedicine organizes a seminar on the role of Nanomedicine in gene therapy and imaging

May 24, 2023 | Laboratory UTCBS, Seminar

1st Seminar on Nanomedicine Applications in Nucleic Acid Delivery and Imaging   “The SFNano (French Society of Nanomedicine) is organizing a seminar on the role of Nanomedicine in gene therapy and imaging. It will take place at the Faculty of Pharmacy of...

seminar in nanomedicine “young researcher” to be held at the Faculty of Pharmacy on June 9

May 24, 2023 | Laboratory UTCBS, Research

Formulations based on phase transition polymers or “Sol-Gel” are an important part of our research. These formulations have the particularity to be totally liquid during manufacturing and to gel during their application, thus conferring multiple...

Imaging in depth in the living

May 15, 2023 | Laboratory UTCBS, Research